THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 95 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 28.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $4,356,000 | -61.2% | 300,000 | -45.5% | 0.15% | -40.8% |
Q1 2021 | $11,226,000 | +14.9% | 550,000 | 0.0% | 0.25% | +7.3% |
Q4 2020 | $9,773,000 | +1.7% | 550,000 | -15.4% | 0.23% | -37.0% |
Q3 2020 | $9,611,000 | +357.9% | 650,072 | +550.1% | 0.37% | +362.5% |
Q2 2020 | $2,099,000 | -9.2% | 100,000 | 0.0% | 0.08% | -25.2% |
Q1 2020 | $2,311,000 | +78.5% | 100,000 | +100.0% | 0.11% | +105.8% |
Q4 2019 | $1,295,000 | -94.3% | 50,000 | -94.3% | 0.05% | -97.2% |
Q4 2018 | $22,645,000 | -37.0% | 884,916 | -19.6% | 1.84% | -21.3% |
Q3 2018 | $35,937,000 | +21.9% | 1,100,000 | -15.4% | 2.34% | +7.1% |
Q2 2018 | $29,484,000 | -6.5% | 1,300,000 | 0.0% | 2.18% | -7.1% |
Q1 2018 | $31,525,000 | +25.6% | 1,300,000 | +44.4% | 2.35% | -10.6% |
Q4 2017 | $25,101,000 | -22.8% | 900,000 | -5.3% | 2.63% | -54.2% |
Q3 2017 | $32,528,000 | -14.1% | 950,000 | 0.0% | 5.74% | -8.5% |
Q2 2017 | $37,848,000 | -27.9% | 950,000 | -33.3% | 6.27% | -17.7% |
Q1 2017 | $52,469,000 | +15.5% | 1,425,000 | 0.0% | 7.62% | +24.4% |
Q4 2016 | $45,429,000 | +12.1% | 1,425,000 | +27.4% | 6.12% | +37.0% |
Q3 2016 | $40,530,000 | +59.7% | 1,118,372 | 0.0% | 4.47% | +24.2% |
Q2 2016 | $25,376,000 | – | 1,118,372 | – | 3.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Madison Avenue Partners, LP | 7,269,584 | $69,497,223,000 | 12.98% |
Newtyn Management, LLC | 1,375,000 | $13,145,000 | 3.15% |
Chescapmanager LLC | 1,166,574 | $11,152,000 | 1.51% |
Baupost Group | 13,643,333 | $130,430,000 | 1.40% |
Weiss Asset Management LP | 5,412,487 | $51,743,000 | 1.07% |
CM Management, LLC | 120,000 | $1,147,000 | 0.96% |
Orbimed Advisors | 3,254,713 | $31,115,000 | 0.50% |
King Wealth Management Group | 122,000 | $1,166,000 | 0.23% |
Woodline Partners LP | 1,326,653 | $12,683,000 | 0.21% |
PDT Partners, LLC | 192,701 | $1,842,000 | 0.16% |